Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

Detalles Bibliográficos
Autores principales: Patel, Jignesh P., Thavarajah, Vassan, Roberts, Lara N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238255/
https://www.ncbi.nlm.nih.gov/pubmed/37274175
http://dx.doi.org/10.1016/j.rpth.2023.100172
_version_ 1785053253676826624
author Patel, Jignesh P.
Thavarajah, Vassan
Roberts, Lara N.
author_facet Patel, Jignesh P.
Thavarajah, Vassan
Roberts, Lara N.
author_sort Patel, Jignesh P.
collection PubMed
description
format Online
Article
Text
id pubmed-10238255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102382552023-06-04 Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis” Patel, Jignesh P. Thavarajah, Vassan Roberts, Lara N. Res Pract Thromb Haemost Letter to the Editor Elsevier 2023-05-09 /pmc/articles/PMC10238255/ /pubmed/37274175 http://dx.doi.org/10.1016/j.rpth.2023.100172 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Patel, Jignesh P.
Thavarajah, Vassan
Roberts, Lara N.
Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title_full Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title_fullStr Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title_full_unstemmed Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title_short Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
title_sort response to “clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238255/
https://www.ncbi.nlm.nih.gov/pubmed/37274175
http://dx.doi.org/10.1016/j.rpth.2023.100172
work_keys_str_mv AT pateljigneshp responsetoclinicallyrelevantincreasesintheinternationalnormalizedratioandmodelofendstageliverdiseasescorebytherapeuticdosesofdirectoralanticoagulantsinpatientswithcirrhosis
AT thavarajahvassan responsetoclinicallyrelevantincreasesintheinternationalnormalizedratioandmodelofendstageliverdiseasescorebytherapeuticdosesofdirectoralanticoagulantsinpatientswithcirrhosis
AT robertslaran responsetoclinicallyrelevantincreasesintheinternationalnormalizedratioandmodelofendstageliverdiseasescorebytherapeuticdosesofdirectoralanticoagulantsinpatientswithcirrhosis

Ejemplares similares